[Effect of 2, 4-diamino-5-p-chlorophenyl-6-ethyl-pyrimidine (daraprim) on the reticuloendothelial system].
D000962:Antimalarials / Q000494:pharmacology*; D012157:Mononuclear Phagocyte System / Q000187:drug effects*; D011739:Pyrimethamine; D011743:Pyrimidines
D000962:Antimalarials; D011743:Pyrimidines; C030986:pyrimidine; D011739:Pyrimethamine
ANTIMALARIALS/effects; RETICULOENDOTHELIAL SYSTEM/effect of drugs on
Acta Physiol Scand. 1951 Sep 21;23(4):283-90
14868526
Klin Wochenschr. 1954 Sep 1;32(33-34):807-9
13202414
J Clin Invest. 1944 Sep;23(5):783-8
16695162
Am J Trop Med Hyg. 1953 Jan;2(1):54-63
13007922
Arztl Forsch. 1956 Aug 10;10(8):I/373-6
13354524
C R Seances Soc Biol Fil. 1951 Oct;145(19-20):1465-6
14926151
Klin Wochenschr. 1956 Feb 1;34(5-6):137-9
13307881
Beitrag zur Wirkung des 2, 4-Diamino-5-p-chlorphenyl-6-äthyl-pyrimidins (Daraprim) auf das RES.